Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 05 2021
Historique:
received: 06 02 2019
revised: 06 02 2019
accepted: 27 03 2019
pubmed: 8 4 2019
medline: 5 8 2021
entrez: 8 4 2019
Statut: ppublish

Résumé

Numerous dose and fractionation schedules have been used to treat medically inoperable stage I non-small cell lung cancer (NSCLC) with stereotactic body radiation therapy (SBRT) or stereotactic ablative radiation therapy. We evaluated published experiences with SBRT to determine local control (LC) rates as a function of SBRT dose. One hundred sixty published articles reporting LC rates after SBRT for stage I NSCLC were identified. Quality of the series was assessed by evaluating the number of patients in the study, homogeneity of the dose regimen, length of follow-up time, and reporting of LC. Clinical data including 1, 2, 3, and 5-year tumor control probabilities for stages T1, T2, and combined T1 and T2 as a function of the biological effective dose were fitted to the linear quadratic, universal survival curve, and regrowth models. Forty-six studies met inclusion criteria. As measured by the goodness of fit χ Early-stage NSCLC is radioresponsive when treated with SBRT or stereotactic ablative radiation therapy. A steep dose-response relationship exists with high rates of durable LC when physical doses of 43-50 Gy are delivered in 3 to 5 fractions.

Identifiants

pubmed: 30954520
pii: S0360-3016(19)30572-3
doi: 10.1016/j.ijrobp.2019.03.045
pmc: PMC9446070
mid: NIHMS1831946
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-171

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

J Clin Oncol. 2009 Jul 10;27(20):3290-6
pubmed: 19414667
Acta Oncol. 2003;42(8):882-94
pubmed: 14968949
Eur J Radiol. 2011 Jul;79(1):147-54
pubmed: 19954913
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):459-65
pubmed: 20385455
Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):707-15
pubmed: 18455322
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1120-8
pubmed: 24661665
J Clin Oncol. 2001 Jan 1;19(1):127-36
pubmed: 11134205
Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):554-60
pubmed: 15890600
Radiother Oncol. 2011 Apr;99(1):12-7
pubmed: 21429608
Curr Oncol. 2012 Aug;19(4):e264-9
pubmed: 22876155
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52
pubmed: 18262098
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):900-7
pubmed: 18262101
Radiother Oncol. 2017 Feb;122(2):286-294
pubmed: 27871671
Pract Radiat Oncol. 2017 Sep - Oct;7(5):295-301
pubmed: 28596092
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1571-8
pubmed: 18374231
J Thorac Cardiovasc Surg. 2010 Sep;140(3):583-9
pubmed: 20478576
J Clin Oncol. 2014 Sep 10;32(26):2847-54
pubmed: 25113761
Radiother Oncol. 2011 May;99(2):176-80
pubmed: 21549440
Clin Chest Med. 2011 Dec;32(4):783-97
pubmed: 22054886
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1343-9
pubmed: 20708849
J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S101-12
pubmed: 17603304
Phys Med Biol. 2016 May 21;61(10):3903-13
pubmed: 27117498
Radiother Oncol. 2007 Dec;85(3):429-34
pubmed: 18022720
Br J Radiol. 2009 May;82(977):421-5
pubmed: 19153186
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1427-31
pubmed: 16169670
Technol Cancer Res Treat. 2015 Aug;14(4):411-8
pubmed: 25261069
J Clin Oncol. 2006 Oct 20;24(30):4833-9
pubmed: 17050868
Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):964-8
pubmed: 23845845
Radiother Oncol. 2012 Jul;104(1):62-6
pubmed: 22682749
Front Oncol. 2012 Jul 11;2:71
pubmed: 22798989
J Thorac Oncol. 2013 Feb;8(2):192-201
pubmed: 23287852
JAMA. 2010 Jun 16;303(23):2368-76
pubmed: 20551407
Radiat Oncol. 2014 May 02;9:106
pubmed: 24885768
Cancer. 2010 Jan 15;116(2):406-14
pubmed: 19950125
Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):404-9
pubmed: 18394819
J Thorac Oncol. 2015 Dec;10(12):1776-84
pubmed: 26334753
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):117-25
pubmed: 16765528
BMJ Case Rep. 2013 Jan 22;2013:
pubmed: 23345491
Front Oncol. 2012 Jun 29;2:63
pubmed: 22754870
Eur J Cancer. 2014 Nov;50(17):2932-8
pubmed: 25281527
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):231-7
pubmed: 22381907
Chest. 2003 Nov;124(5):1946-55
pubmed: 14605072
J Bras Pneumol. 2014 Jan-Feb;40(1):21-9
pubmed: 24626266
Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):203-8
pubmed: 25015198
Med Phys. 2008 Jun;35(6):2259-66
pubmed: 18649456
Radiother Oncol. 2014 Aug;112(2):250-5
pubmed: 25236716
Chest. 2013 May;143(5 Suppl):e211S-e250S
pubmed: 23649440
J Thorac Oncol. 2008 Dec;3(12):1433-8
pubmed: 19057269
Radiat Oncol. 2012 Oct 31;7:182
pubmed: 23110967
Expert Rev Med Devices. 2012 Sep;9(5):465-75
pubmed: 23116073
J Thorac Oncol. 2012 Jun;7(6):1021-5
pubmed: 22551902
Med Dosim. 2007 Summer;32(2):86-91
pubmed: 17472887
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1146-50
pubmed: 19800181
Radiother Oncol. 2005 Nov;77(2):182-90
pubmed: 16256231
Lung Cancer. 2014 Jul;85(1):59-65
pubmed: 24813936
Chest. 2012 Dec;142(6):1620-1635
pubmed: 23208335
J Thorac Oncol. 2012 Sep;7(9):1394-9
pubmed: 22843088
Radiother Oncol. 2017 Jul;124(1):11-17
pubmed: 28687397
Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1104-11
pubmed: 20472343
Radiat Oncol J. 2013 Dec;31(4):247-51
pubmed: 24501714
JAMA. 2010 Mar 17;303(11):1070-6
pubmed: 20233825
Cancer. 2007 Jul 1;110(1):148-55
pubmed: 17516437
Radiother Oncol. 2012 Nov;105(2):145-9
pubmed: 23068707
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):112-8
pubmed: 18786780
J Thorac Dis. 2014 Apr;6(4):303-18
pubmed: 24688775
J Appl Clin Med Phys. 2006 May 25;7(2):58-63
pubmed: 17533331
Radiother Oncol. 2009 Jun;91(3):296-300
pubmed: 19297048
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1060-70
pubmed: 22975611
Lung Cancer. 2008 May;60(2):193-9
pubmed: 18045732
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1168-76
pubmed: 25303891
Clin Lung Cancer. 2014 Jul;15(4):287-93
pubmed: 24594401
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):126-35
pubmed: 12694831
Lung Cancer. 2003 Jul;41(1):1-11
pubmed: 12826306
Future Oncol. 2010 Feb;6(2):305-17
pubmed: 20146589
Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1014-23
pubmed: 12419427
J Thorac Oncol. 2012 Sep;7(9):1382-93
pubmed: 22843086
Cancer. 2000 Dec 1;89(11 Suppl):2334-44
pubmed: 11147608
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):374-81
pubmed: 18029106
Radiother Oncol. 2009 Dec;93(3):402-7
pubmed: 19559492
Radiat Oncol. 2013 Mar 21;8:69
pubmed: 23518013
Strahlenther Onkol. 2013 Jan;189(1):33-40
pubmed: 23179248
Ann Thorac Surg. 1995 Sep;60(3):615-22; discussion 622-3
pubmed: 7677489
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):344-9
pubmed: 19765913
Pract Radiat Oncol. 2012 Oct-Dec;2(4):288-295
pubmed: 24674167
World J Clin Oncol. 2014 Oct 10;5(4):595-603
pubmed: 25302164
Radiother Oncol. 2011 Apr;99(1):18-22
pubmed: 21458087
Semin Thorac Cardiovasc Surg. 2010 Spring;22(1):44-52
pubmed: 20813316
Radiat Oncol. 2012 Jun 24;7:102
pubmed: 22726884
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e299-303
pubmed: 21477948
Radiat Oncol. 2009 Jan 27;4:4
pubmed: 19173738
Med Phys. 2017 Jul;44(7):3815-3820
pubmed: 28398596
Lung Cancer. 2010 Apr;68(1):72-7
pubmed: 19556022
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):442-8
pubmed: 18990507
Phys Med. 2013 Jun;29(4):333-40
pubmed: 22617761
Acta Oncol. 2006;45(7):787-95
pubmed: 16982541
Jpn J Clin Oncol. 2010 Feb;40(2):125-9
pubmed: 19825814
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1558-65
pubmed: 22572078
Lung Cancer. 2005 Apr;48(1):107-14
pubmed: 15777977
Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1597-603
pubmed: 19028283
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):483-91
pubmed: 16904838
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087
Semin Oncol. 2014 Feb;41(1):40-56
pubmed: 24565580
Br J Radiol. 2016;89(1059):20150963
pubmed: 26764282
J Thorac Oncol. 2009 Aug;4(8):976-82
pubmed: 19633473

Auteurs

Percy Lee (P)

Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California. Electronic address: percylee@mednet.ucla.edu.

Billy W Loo (BW)

Department of Radiation Oncology, Stanford University, Stanford, California.

Tithi Biswas (T)

Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, Ohio.

George X Ding (GX)

Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee.

Issam M El Naqa (IM)

Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, Michigan.

Andrew Jackson (A)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Feng-Ming Kong (FM)

Department of Radiation Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Tamara LaCouture (T)

Department of Radiation Oncology, Jefferson Health New Jersey, Sewell, New Jersey.

Moyed Miften (M)

Department of Radiation Oncology, Colorado University School of Medicine, Aurora, Colorado.

Timothy Solberg (T)

Department of Radiation Oncology, University of California at San Francisco, San Francisco, California.

Wolfgang A Tome (WA)

Department of Radiation Oncology, Albert Einstein College of Medicine, New York, New York.

An Tai (A)

Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Ellen Yorke (E)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

X Allen Li (XA)

Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH